Vyndaqel (Tafamidis meglumine Capsule) 20mg

Vyndaqel (tafamidis meglumine) 20mg capsules are used for transthyretin amyloidosis management. This oral treatment supports protein stabilization to slow disease progression. Ideal for patients seeking disease-modifying therapy. Store at room temperature for convenience.

Strength

20mg

Pack Size

120s

Storage

Ambient

Manufacturer / TM Owner

Pfizer Pharm

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Vyndaqel is prescribed to treat transthyretin amyloidosis, a condition where abnormal proteins build up and damage organs. It is used for both hereditary and wild-type forms of the disease. The 20mg capsule helps stabilize transthyretin, reducing amyloid fibril formation. Patients often ask, 'what is tafamidis meglumine used for' to manage symptoms and progression.

Side Effects

Many patients report improved quality of life while taking Vyndaqel, as it may slow disease-related decline. Common effects include gastrointestinal comfort and reduced fatigue in some cases. Individual responses vary, and benefits are typically assessed over time by healthcare providers.

Precautions & Warnings

Store Vyndaqel at room temperature away from moisture and heat. Keep capsules in their original packaging until use to maintain potency. Always handle with dry hands to prevent moisture exposure. Consult a healthcare professional before starting or stopping this medication.

Avoid Interactions

Vyndaqel may interact with medications that affect liver enzymes, such as certain CYP3A4 inhibitors or inducers. Alcohol use should be discussed with a doctor, as it may influence treatment effects. Always inform your healthcare provider about all medications and supplements you are taking.

Frequently Asked Questions

Vyndaqel is used to treat transthyretin amyloidosis, a rare disease caused by protein buildup.

Store Vyndaqel at room temperature in a dry place, away from direct sunlight.

Consult your doctor before combining Vyndaqel with other drugs to avoid potential interactions.

Some patients report mild gastrointestinal effects, but individual experiences vary.

No, Vyndaqel requires a prescription from a licensed healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.